Commissioning and performance evaluation of commercially available mobile imager for image guided total body irradiation
- PMID: 36573258
- PMCID: PMC10113699
- DOI: 10.1002/acm2.13865
Commissioning and performance evaluation of commercially available mobile imager for image guided total body irradiation
Abstract
Background: The setup of lung shield (LS) in total body irradiation (TBI) with the computed radiography (CR) system is a time-consuming task and has not been quantitatively evaluated. The TBI mobile imager (TBI-MI) can solve this problem through real-time monitoring. Therefore, this study aimed to perform commissioning and performance evaluation of TBI-MI to promote its use in clinical practice.
Methods: The source-axis distance in TBI treatment, TBI-MI (CNERGY TBI, Cablon Medical B.V.), and the LS position were set to 400, 450, and 358 cm, respectively. The evaluation items were as follows: accuracy of image scaling and measured displacement error of LS, image quality (linearity, signal-to-noise ratio, and modulation transfer function) using an EPID QC phantom, optimal thresholding to detect intra-fractional motion in the alert function, and the scatter radiation dose from TBI-MI.
Results: The accuracy of image scaling and the difference in measured displacement of the LS was <4 mm in any displacements and directions. The image quality of TBI imager was slightly inferior to the CR image but was visually acceptable in clinical practice. The signal-to-noise ratio was improved at high dose rate. The optimal thresholding value to detect a 10-mm body displacement was determined to be approximately 5.0%. The maximum fraction of scattering radiation to irradiated dose was 1.7% at patient surface.
Conclusion: MI-TBI can quantitatively evaluate LS displacement with acceptable image quality. Furthermore, real-time monitoring with alert function to detect intrafraction patient displacement can contribute to safe TBI treatment.
Keywords: EPID; TBI; in vivo dosimetry; lung shield; mobile imager; real-time monitoring.
© 2022 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.
Conflict of interest statement
H. O has a research grant from Item Corporation.
Figures











References
-
- Ishibashi N, Soejima T, Kawaguchi H, et al. Japanese Radiation Oncology Study Group. National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG). J Radiat Res. 2018;59(4):477‐483. - PMC - PubMed
-
- Giebel S, Miszczyk L, Slosarek K, et al. Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Cancer. 2014;120(17):2760‐2765. - PubMed
-
- Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ. Sequential regimen of chemotherapy, reduced‐intensity conditioning for allogeneic stem‐cell transplantation, and prophylactic donor lymphocyte transfusion in high‐risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005;23(24):5675‐5687. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources